AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Strategic Asset Allocation Index
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of €- plus long-term investments of €0.00) total €0.00, measured against net assets of €33.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
AEST.MED.INT.HLD.SP.ADR/3 Strategic Asset Allocation Index (2023–2023)
This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Strategic Asset Allocation Index has evolved across 1 annual periods from 2023 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of €0.00 against net assets of €33.63 Million EUR. Explore AEST.MED.INT.HLD.SP.ADR/3 (3FMA) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for AEST.MED.INT.HLD.SP.ADR/3 (2023–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for AEST.MED.INT.HLD.SP.ADR/3 from 2023 to 2023, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see AEST.MED.INT.HLD.SP.ADR/3 (3FMA) total market value.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | €0.00 | €- | €0.00 | €33.63 Million | — |